RPath president Dr Bernie Croal discusses the evolving landscape of pathology in the UK, the challenges and opportunities, ...

A new study highlights the risks of atopic dermatitis flare-ups after discontinuing dupilumab and the likelihood of ...

Vulnerable premature babies needing extra protection against RSV will receive a long-lasting single injection of nirsevimab, says NHSE.

Dr Urmas Sule details how Estonia weathered the significant challenges of 2022 and his hopes and expectations for 2023.

E. coli is capable of turning plastic waste into paracetamol and could offer a new and sustainable production method, says new study.

Glyphosate is a commonly used herbicides and a study in farmers observed positive associations with biomarkers of oxidative DNA damage Regular use of the herbicide glyphosate among farmers is ...

A new inherited DNA repair deficiency syndrome called DIAL syndrome, which increases blood cancer risk and chemo toxicity has been identified.

Further measures to be introduced to highlight risk of neuropsychiatric reactions in patients prescribed montelukast for asthma.

Pembrolizumab therapy in patients with high-risk, non-muscle-invasive bladder cancer unresponsive to BCG treatment shows anti-tumour activity Data presented at the 2023 American Society for Clinical ...

A significant five-year overall survival rate has been observed with the use of neoadjuvant nivolumab in resectable non-small cell lung cancer. In the current study, a team from Johns Hopkins Sidney ...

Patients with myocardial infarction have a significantly increased risk of developing serious long-term health conditions, new study finds.

Almost one in 10 doctors in the EU intend to leave their profession, highlighting widespread retention issues, the METEOR Project shows.